BSE Live
Nov 28, 16:01Prev. Close
2248.95
Open Price
2249.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 28, 15:59Prev. Close
2249.30
Open Price
2259.80
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2251.00 (35)
| Balance Sheet of Mankind Pharma (in Rs. Cr.) | Mar 20 | |
| 12 mths | ||
| EQUITIES AND LIABILITIES | ||
| SHAREHOLDER'S FUNDS | ||
| Equity Share Capital | 40.06 | |
| Total Share Capital | 40.06 | |
| Reserves and Surplus | 3,445.25 | |
| Total Reserves and Surplus | 3,445.25 | |
| Total Shareholders Funds | 3,485.31 | |
| Minority Interest | 186.26 | |
| NON-CURRENT LIABILITIES | ||
| Long Term Borrowings | 53.17 | |
| Deferred Tax Liabilities [Net] | 8.17 | |
| Other Long Term Liabilities | 18.79 | |
| Long Term Provisions | 63.01 | |
| Total Non-Current Liabilities | 143.13 | |
| CURRENT LIABILITIES | ||
| Short Term Borrowings | 77.72 | |
| Trade Payables | 745.11 | |
| Other Current Liabilities | 220.09 | |
| Short Term Provisions | 215.67 | |
| Total Current Liabilities | 1,258.59 | |
| Total Capital And Liabilities | 5,073.29 | |
| ASSETS | ||
| NON-CURRENT ASSETS | ||
| Tangible Assets | 1,556.90 | |
| Intangible Assets | 22.25 | |
| Capital Work-In-Progress | 313.26 | |
| Fixed Assets | 1,896.11 | |
| Non-Current Investments | 164.39 | |
| Deferred Tax Assets [Net] | 47.94 | |
| Long Term Loans And Advances | 0.10 | |
| Other Non-Current Assets | 122.09 | |
| Total Non-Current Assets | 2,251.07 | |
| CURRENT ASSETS | ||
| Current Investments | 665.03 | |
| Inventories | 899.14 | |
| Trade Receivables | 531.09 | |
| Cash And Cash Equivalents | 419.88 | |
| Short Term Loans And Advances | 34.50 | |
| OtherCurrentAssets | 272.58 | |
| Total Current Assets | 2,822.22 | |
| Total Assets | 5,073.29 | |
| OTHER ADDITIONAL INFORMATION | ||
| CONTINGENT LIABILITIES, COMMITMENTS | ||
| Contingent Liabilities | 88.52 | |
| BONUS DETAILS | ||
| Bonus Equity Share Capital | 0.52 | |
| NON-CURRENT INVESTMENTS | ||
| Non-Current Investments Quoted Market Value | 0.00 | |
| Non-Current Investments Unquoted Book Value | 164.39 | |
| CURRENT INVESTMENTS | ||
| Current Investments Quoted Market Value | 0.00 | |
| Current Investments Unquoted Book Value | 665.03 |
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
11.11.2025
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
07.11.2025
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y
01.08.2025
Mankind Pharma Consolidated June 2025 Net Sales at Rs 3,570.35 crore, up 23.4% Y-o-Y
01.08.2025
Mankind Pharma Standalone June 2025 Net Sales at Rs 2,541.36 crore, up 5.75% Y-o-Y